New Zealand markets open in 4 hours 48 minutes

Ovid Therapeutics Inc. (OVID)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.0300-0.0600 (-1.94%)
As of 12:49PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts8887
Avg. Estimate-0.22-0.22-0.86-0.41
Low estimate-0.26-0.28-1.07-1.01
High estimate-0.17-0.18-0.731.42
Year ago EPS-0.19-0.18-0.74-0.86
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts7778
Avg. Estimate60k70k2.54M43.7M
Low estimateN/AN/AN/A870k
High estimate170k190k16.3M179.4M
Year ago sales66k75k392k2.54M
Sales growth (year/est)-9.10%-6.70%548.00%1,620.50%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.17-0.2-0.19-0.05
Actual EPS-0.19-0.18-0.16-0.22
Difference-0.020.020.03-0.17
Surprise %-11.80%10.00%15.80%-340.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.22-0.22-0.86-0.41
7 days ago-0.22-0.22-0.86-0.41
30 days ago-0.21-0.21-0.84-0.28
60 days ago-0.18-0.19-0.66-0.04
90 days ago-0.18-0.19-0.66-0.04
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1111
Growth estimatesOVIDIndustrySector(s)S&P 500
Current qtr.-15.80%N/AN/AN/A
Next qtr.-22.20%N/AN/AN/A
Current year-16.20%N/AN/AN/A
Next year52.30%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A